The novel pretreatment immune prognostic index discriminates survival outcomes in locally advanced non-operative esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy: a 6-year retrospective study

OBJECTIVE: We aimed to construct risk stratification to help set individualized treatment strategies and intensities for different subgroups of patients. METHODS: The Esophagus Immune Prognostic Index (EIPI) scores were constructed according to the levels of derived neutrophil-to-lymphocyte ratio (d...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yilin, Wu, Haishan, Qiu, Jianjian, Ke, Dongmei, Wu, Yahua, Lin, Mingqiang, Zheng, Qunhao, Zheng, Hongying, Wang, Zhiping, Li, Hui, Liu, Lingyun, Li, Jiancheng, Yao, Qiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046998/
https://www.ncbi.nlm.nih.gov/pubmed/35452997
http://dx.doi.org/10.1016/j.tranon.2022.101430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046998/
https://www.ncbi.nlm.nih.gov/pubmed/35452997
http://dx.doi.org/10.1016/j.tranon.2022.101430

Ejemplares similares